Developing next-generation cardiac regenerative medicine, leveraging AI-driven bioprocessing to transform heart failure treatment
CytoHub Inc. has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2025.
CytoHub Inc. is headquartered in San Diego, United States.
Developing next-generation cardiac regenerative medicine, leveraging AI-driven bioprocessing to transform heart failure treatment
CytoHub Inc. is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoHub Inc. — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/cytohub-inc. Accessed August 14, 2026.
VCBacked. (2025). CytoHub Inc. — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cytohub-inc
{{cite web |title=CytoHub Inc. — Funding & Investors |url=https://www.vcbacked.co/company/cytohub-inc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated